Figure 6: Model for the biomechanical reprogramming of PSCs.

ATRA downregulates myosin II-dependent force generation and mechanosensing in PSCs. PSCs are reprogrammed to a more quiescent phenotype, cannot migrate, remodel the ECM or promote cancer invasion.